Literature DB >> 24050165

Interaction between bone and muscle in older persons with mobility limitations.

L Ferrucci, M Baroni, A Ranchelli, F Lauretani, M Maggio, P Mecocci, C Ruggiero1.   

Abstract

Aging is associated with a progressive loss of bone-muscle mass and strength. When the decline in mass and strength reaches critical thresholds associated with adverse health outcomes, they are operationally considered geriatric conditions and named, respectively, osteoporosis and sarcopenia. Osteoporosis and sarcopenia share many of the same risk factors and both directly or indirectly cause higher risk of mobility limitations, falls, fractures and disability in activities of daily living. This is not surprising since bones adapt their morphology and strength to the long-term loads exerted by muscle during anti-gravitational and physical activities. Non-mechanical systemic and local factors also modulate the mechanostat effect of muscle on bone by affecting the bidirectional osteocyte-muscle crosstalk, but the specific pathways that regulate these homeostatic mechanisms are not fully understood. More research is required to reach a consensus on cut points in bone and muscle parameters that identify individuals at high risk for adverse health outcomes, including falls, fractures and disability. A better understanding of the muscle-bone physiological interaction may help to develop preventive strategies that reduce the burden of musculoskeletal diseases, the consequent disability in older persons and to limit the financial burden associated with such conditions. In this review, we summarize age-related bone-muscle changes focusing on the biomechanical and homeostatic mechanisms that explain bone-muscle interaction and we speculate about possible pathological events that occur when these mechanisms become impaired. We also report some recent definitions of osteoporosis and sarcopenia that have emerged in the literature and their implications in clinical practice. Finally, we outline the current evidence for the efficacy of available anti-osteoporotic and proposed antisarcopenic interventions in older persons.

Entities:  

Mesh:

Year:  2014        PMID: 24050165      PMCID: PMC4586132          DOI: 10.2174/13816128113196660690

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  336 in total

Review 1.  Serum 25-hydroxyvitamin D and functional outcomes in the elderly.

Authors:  Bess Dawson-Hughes
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

2.  Trabecular and cortical bone density and architecture in women after 60 days of bed rest using high-resolution pQCT: WISE 2005.

Authors:  Gabriele Armbrecht; Daniel Ludovic Belavý; Magdalena Backström; Gisela Beller; Christian Alexandre; Rene Rizzoli; Dieter Felsenberg
Journal:  J Bone Miner Res       Date:  2011-10       Impact factor: 6.741

Review 3.  Consequences of sarcopenia.

Authors:  Marjolein Visser; Laura A Schaap
Journal:  Clin Geriatr Med       Date:  2011-05-14       Impact factor: 3.076

Review 4.  Sarcopenia: characteristics, mechanisms and functional significance.

Authors:  Marco V Narici; Nicola Maffulli
Journal:  Br Med Bull       Date:  2010-03-02       Impact factor: 4.291

5.  A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the Frailty Interventions Trial in Elderly Subjects (FITNESS).

Authors:  Nancy K Latham; Craig S Anderson; Arier Lee; Derrick A Bennett; Anne Moseley; Ian D Cameron
Journal:  J Am Geriatr Soc       Date:  2003-03       Impact factor: 5.562

6.  The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study.

Authors:  Bret H Goodpaster; Seok Won Park; Tamara B Harris; Steven B Kritchevsky; Michael Nevitt; Ann V Schwartz; Eleanor M Simonsick; Frances A Tylavsky; Marjolein Visser; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-10       Impact factor: 6.053

7.  Axial bone mass in older women. Study of Osteoporotic Fractures Research Group.

Authors:  E S Orwoll; D C Bauer; T M Vogt; K M Fox
Journal:  Ann Intern Med       Date:  1996-01-15       Impact factor: 25.391

Review 8.  Mechanical loading influences bone mass through estrogen receptor alpha.

Authors:  Karla C L Lee; Lance E Lanyon
Journal:  Exerc Sport Sci Rev       Date:  2004-04       Impact factor: 6.230

Review 9.  The role of systemic inflammation in age-related muscle weakness and wasting.

Authors:  H Degens
Journal:  Scand J Med Sci Sports       Date:  2009-09-29       Impact factor: 4.221

10.  The bone-muscle relationship in men and women.

Authors:  Thomas F Lang
Journal:  J Osteoporos       Date:  2011-10-05
View more
  26 in total

Review 1.  Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases.

Authors:  Rita Rastogi Kalyani; Mark Corriere; Luigi Ferrucci
Journal:  Lancet Diabetes Endocrinol       Date:  2014-03-06       Impact factor: 32.069

Review 2.  Aging, inflammation and the environment.

Authors:  Arsun Bektas; Shepherd H Schurman; Ranjan Sen; Luigi Ferrucci
Journal:  Exp Gerontol       Date:  2017-12-21       Impact factor: 4.032

Review 3.  Exosomes and Extracellular RNA in Muscle and Bone Aging and Crosstalk.

Authors:  Weiping Qin; Sarah L Dallas
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

4.  Effects of 4-Aminopyridine on Combined Nerve and Muscle Injury and Bone Loss.

Authors:  Prem Kumar Govindappa; Mashanipalya G Jagadeeshaprasad; Peter Tortora; M A Hassan Talukder; John C Elfar
Journal:  J Hand Surg Am       Date:  2022-04-10       Impact factor: 2.342

Review 5.  Muscle-bone and fat-bone interactions in regulating bone mass: do PTH and PTHrP play any role?

Authors:  Nabanita S Datta
Journal:  Endocrine       Date:  2014-05-07       Impact factor: 3.633

6.  Higher Hand Grip Strength Is Associated With Greater Radius Bone Size and Strength in Older Men and Women: The Framingham Osteoporosis Study.

Authors:  Robert R McLean; Elizabeth J Samelson; Amanda L Lorbergs; Kerry E Broe; Marian T Hannan; Steven K Boyd; Mary L Bouxsein; Douglas P Kiel
Journal:  JBMR Plus       Date:  2021-03-30

Review 7.  The Neuromuscular Junction: Aging at the Crossroad between Nerves and Muscle.

Authors:  Marta Gonzalez-Freire; Rafael de Cabo; Stephanie A Studenski; Luigi Ferrucci
Journal:  Front Aging Neurosci       Date:  2014-08-11       Impact factor: 5.750

Review 8.  Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia.

Authors:  Jean-Yves Reginster; Cyrus Cooper; René Rizzoli; John A Kanis; Geoff Appelboom; Ivan Bautmans; Heike A Bischoff-Ferrari; Maarten Boers; Maria Luisa Brandi; Olivier Bruyère; Antonio Cherubini; Bruno Flamion; Roger A Fielding; Andrea Ildiko Gasparik; Luc Van Loon; Eugene McCloskey; Bruce H Mitlak; Alberto Pilotto; Suzanne Reiter-Niesert; Yves Rolland; Yannis Tsouderos; Marjolein Visser; Alfonso J Cruz-Jentoft
Journal:  Aging Clin Exp Res       Date:  2015-12-30       Impact factor: 3.636

9.  Eldecalcitol, an Active Vitamin D3 Derivative, Prevents Trabecular Bone Loss and Bone Fragility in Type I Diabetic Model Rats.

Authors:  Satoshi Takeda; Mitsuru Saito; Sadaoki Sakai; Kenji Yogo; Keishi Marumo; Koichi Endo
Journal:  Calcif Tissue Int       Date:  2017-06-17       Impact factor: 4.333

Review 10.  Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis.

Authors:  Valentina Cappello; Maura Francolini
Journal:  Int J Mol Sci       Date:  2017-10-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.